A global clinical trial testing Ultomiris (ravulizumab-cwvz) in adults with neuromyelitis optica spectrum disorder (NMOSD) found that the treatment kept patients free of relapses for more than 4.5 years. When compared with data from an external group of NMOSD patients given a placebo in a previous trial, the…
Discussion
If you had asked me years ago what productivity meant, I would have rattled off the usual corporate nonsense: doing more, pushing harder, staying available, and proving I could outrun exhaustion like it was a competitive sport. I treated productivity like a personality trait, something I could earn through sheer…
Discussion
Children with neuromyelitis optica spectrum disorder (NMOSD) are more likely to have severe vision problems and incomplete visual recovery than those with the related condition myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). That’s according to a review of published studies involving children with NMOSD associated with antibodies against the aquaporin-4…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
